Daily Archives: February 23, 2006

Class of One – Avoiding Warning Letters, Part II

According to FDA regulations, one cannot state a claim that one’s drug or biologic is superior to another unless there has been a head to head study demonstrating that superiority. That regulatory reality can be frustrating to communications professionals who … Continue reading

Posted in Regulatory Communications, Warning Letters | 1 Comment